Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2076185rdf:typepubmed:Citationlld:pubmed
pubmed-article:2076185lifeskim:mentionsumls-concept:C0032043lld:lifeskim
pubmed-article:2076185lifeskim:mentionsumls-concept:C0439861lld:lifeskim
pubmed-article:2076185lifeskim:mentionsumls-concept:C0024262lld:lifeskim
pubmed-article:2076185lifeskim:mentionsumls-concept:C1749467lld:lifeskim
pubmed-article:2076185lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:2076185lifeskim:mentionsumls-concept:C0443199lld:lifeskim
pubmed-article:2076185lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:2076185lifeskim:mentionsumls-concept:C1709059lld:lifeskim
pubmed-article:2076185lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:2076185pubmed:issue3lld:pubmed
pubmed-article:2076185pubmed:dateCreated1991-4-19lld:pubmed
pubmed-article:2076185pubmed:abstractTextSoluble and detergent-solubilized placental extracts were studied for their modulatory effects upon the proliferation of lymphocytes stimulated by various activating agents. It was shown that soluble placental extract (SPE) exerted an inhibitory effect on the lymphoproliferation triggered by alloantigen or LPS but not by Con A or the combined action of PMA + calcium ionophore A 23187. This effect was also observed with SPE precipitated by 30% of ammonium sulfate (SPE30). On the other hand, a solubilized placental extract (SzPE) that was obtained by using octyl-beta-D-glucopyranoside inhibited the stimulation triggered by alloantigen, LPS, and Con A but did not affect the protein kinase C pathway. The modulatory effects were observed not only when SPE (or SPE30) and SzPE were added at the time of culture initiation but also at 24 h before or after the activating agents. Preincubation with SPE30 or SzPE immobilized on plastic surface, however, transduced an enhanced lymphoproliferative response to alloantigen and mitogen Con A but not to LPS. The above results suggest that placental substances exerted their modulatory effects by interfering mainly with the antigen or mitogen lymphoproliferation pathways.lld:pubmed
pubmed-article:2076185pubmed:languageenglld:pubmed
pubmed-article:2076185pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2076185pubmed:citationSubsetIMlld:pubmed
pubmed-article:2076185pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2076185pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2076185pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2076185pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2076185pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2076185pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2076185pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2076185pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2076185pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2076185pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2076185pubmed:statusMEDLINElld:pubmed
pubmed-article:2076185pubmed:monthNovlld:pubmed
pubmed-article:2076185pubmed:issn1046-7408lld:pubmed
pubmed-article:2076185pubmed:authorpubmed-author:VoisinG AGAlld:pubmed
pubmed-article:2076185pubmed:authorpubmed-author:DucH THTlld:pubmed
pubmed-article:2076185pubmed:authorpubmed-author:NakagawaSSlld:pubmed
pubmed-article:2076185pubmed:authorpubmed-author:RighenziSSlld:pubmed
pubmed-article:2076185pubmed:authorpubmed-author:RucayPPlld:pubmed
pubmed-article:2076185pubmed:issnTypePrintlld:pubmed
pubmed-article:2076185pubmed:volume24lld:pubmed
pubmed-article:2076185pubmed:ownerNLMlld:pubmed
pubmed-article:2076185pubmed:authorsCompleteYlld:pubmed
pubmed-article:2076185pubmed:pagination73-9lld:pubmed
pubmed-article:2076185pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2076185pubmed:meshHeadingpubmed-meshheading:2076185-...lld:pubmed
pubmed-article:2076185pubmed:meshHeadingpubmed-meshheading:2076185-...lld:pubmed
pubmed-article:2076185pubmed:meshHeadingpubmed-meshheading:2076185-...lld:pubmed
pubmed-article:2076185pubmed:meshHeadingpubmed-meshheading:2076185-...lld:pubmed
pubmed-article:2076185pubmed:meshHeadingpubmed-meshheading:2076185-...lld:pubmed
pubmed-article:2076185pubmed:meshHeadingpubmed-meshheading:2076185-...lld:pubmed
pubmed-article:2076185pubmed:meshHeadingpubmed-meshheading:2076185-...lld:pubmed
pubmed-article:2076185pubmed:meshHeadingpubmed-meshheading:2076185-...lld:pubmed
pubmed-article:2076185pubmed:meshHeadingpubmed-meshheading:2076185-...lld:pubmed
pubmed-article:2076185pubmed:meshHeadingpubmed-meshheading:2076185-...lld:pubmed
pubmed-article:2076185pubmed:meshHeadingpubmed-meshheading:2076185-...lld:pubmed
pubmed-article:2076185pubmed:meshHeadingpubmed-meshheading:2076185-...lld:pubmed
pubmed-article:2076185pubmed:meshHeadingpubmed-meshheading:2076185-...lld:pubmed
pubmed-article:2076185pubmed:meshHeadingpubmed-meshheading:2076185-...lld:pubmed
pubmed-article:2076185pubmed:meshHeadingpubmed-meshheading:2076185-...lld:pubmed
pubmed-article:2076185pubmed:meshHeadingpubmed-meshheading:2076185-...lld:pubmed
pubmed-article:2076185pubmed:meshHeadingpubmed-meshheading:2076185-...lld:pubmed
pubmed-article:2076185pubmed:meshHeadingpubmed-meshheading:2076185-...lld:pubmed
pubmed-article:2076185pubmed:meshHeadingpubmed-meshheading:2076185-...lld:pubmed
pubmed-article:2076185pubmed:year1990lld:pubmed
pubmed-article:2076185pubmed:articleTitleDifferential modulation of the in vitro lymphocyte activation pathways by soluble and solubilized placental substances.lld:pubmed
pubmed-article:2076185pubmed:affiliationImmunogénétique des Allogreffes, Hôpital Paul Brousse, Villejuif, France.lld:pubmed
pubmed-article:2076185pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2076185pubmed:publicationTypeComparative Studylld:pubmed